本栏目中汇集了健康网（http://www.healthoo.com）自2004年至今发表在各
种医药行业重要媒体上的分析文章和评论。这些文章是公司首席研究员吴惠芳女士
所带领的团队研究成果的精粹，现整理出来，供大家回顾，也方便记者参考。
主要作者：
吴惠芳 女士，现任北京东方比特科技有限公司（健康网）副总经理，兼首席
研究员。负责公司日常管理和业务运营。
吴女士从事药学研究与实践二十多年。2000年前在部队医疗科研机构从事临床
药学，技术职务副主任药师。2000年退役后从事医药信息研究工作，专注于医药行
业研究、市场研究、产业链结构等领域。为国内外著名企业（诺华、辉瑞、葛兰素
史克、DSM、阿斯利康、华北制药、石药集团、上药集团、哈药集团等）提供专项
调研报告。
吴女士在军事医学科学院获理学硕士学位，是《中国医药报》、《医药经济报
》的特约撰稿人，在国内重要医药报刊发表大量文章。多次被邀请在中国医药行业
大型会议和展览上（中国原料药国际交易会，中国制药大会等）做有关中国医药市
场专题报告。她的报告以实际数据和案例阐明问题、总结变化规律，在中国制药企
业中广为流传，被作为专家受到中国医药界的欢迎。
Huifang Wu is Vice President of Beijing Orientbit Technology Co.,
Ltd, responsible for company general management and business operation.
Ms Wu has over 20 year’s experiences in pharmaceutical research
and clinical pharmacy. She had worked in the PLA medical institutions
before 2000,as the Deputy Director pharmacist and as a Licensed Pharma-
cist. Since 2000, she has been focusing on researching and studying
medical information, in areas including the China pharmaceutical indu-
stry assessment, market research, supply chain structure analysis, etc.
Her clients include many famous domestic and global pharmaceutical
enterprises (Novartis,Pfizer,Glaxo SmithKline, DSM,AstraZeneca,North
China Pharmaceutical,Shijiazhuang Pharmaceutical Group,ShangHai Pharma-
ceutical Group, Harbin Pharmaceutical Group).
Ms Wu received her master’s degree from The Academy of Military
Medical Sciences (AMMS).She is a contributing author for "China Pharma-
ceutical News" and "Medicine Economic News". She publishes many arti-
cles in major newspapers and journals. Ms Wu has been frequently
invited to speak at China pharmaceutical conferences and tradeshows
such as APIs China, IBC conference in China, IPC China. Her presenta-
tions are widely circulated in the China pharmaceutical industry and
are renowned for its factual data and case for problem-solving, and
industrial trend analysis. She is recognized as an expert by many pro-
fessionals of Chinese pharmaceutical industry.
(.00014001X06.)
| 
